GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » Debt-to-Revenue

Curative Biosciences (Curative Biosciences) Debt-to-Revenue : N/A (As of Mar. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Curative Biosciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2018 was $0.34 Mil. Curative Biosciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2018 was $0.00 Mil. Curative Biosciences's annualized Revenue for the quarter that ended in Mar. 2018 was $0.00 Mil.


Curative Biosciences Debt-to-Revenue Historical Data

The historical data trend for Curative Biosciences's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences Debt-to-Revenue Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - N/A N/A N/A N/A

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Curative Biosciences's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curative Biosciences's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Debt-to-Revenue falls into.



Curative Biosciences Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Curative Biosciences's Debt-to-Revenue for the fiscal year that ended in Jun. 2017 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.063 + 0) / N/A
=N/A

Curative Biosciences's annualized Debt-to-Revenue for the quarter that ended in Mar. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2018) Revenue data.


Curative Biosciences Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biosciences (Curative Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines